MYIA
INSM icon

Mount Yale Investment Advisors’s Insmed INSM Stock Holding History

Mount Yale Investment Advisors’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$601K Buy
3,674
+1,925
+110% +$296K 0.01% 664
2025
Q4 		$304K Buy
+1,749
New +$319K 0.01% 594
2025
Q3 		– Sell
-1,685
Closed -$170K – 1117
2025
Q2 		$170K Sell
1,685
-1,712
-50% -$131K 0.01% 566
2025
Q1 		$259K Sell
3,397
-37
-1% -$2.83K 0.02% 470
2024
Q4 		$237K Sell
3,434
-118
-3% -$8.5K 0.02% 500
2024
Q3 		$259K Buy
+3,552
New +$262K 0.02% 477

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Mount Yale Investment Advisors's INSM Position: Q1 2026 in Review

Mount Yale Investment Advisors increased its Insmed (INSM) stake by 110% in Q1 2026, buying an estimated $296K and bringing the position to 3,674 shares worth $601K. The position accounts for 0.01% of the portfolio, ranked #664.

Mount Yale Investment Advisors first reported a position in INSM in Q3 2024 and has held it in 6 quarters since. 672 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Mount Yale Investment Advisors held 3,674 shares of Insmed worth $601K as of Q1 2026.
  • Mount Yale Investment Advisors bought 1,925 Insmed shares in Q1 2026, an estimated $296K.
  • Insmed made up 0.01% of Mount Yale Investment Advisors's portfolio in Q1 2026, its #664 holding.
  • Mount Yale Investment Advisors first reported a position in Insmed in Q3 2024 and has held it in 6 quarters since.
  • 672 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Mount Yale Investment Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.